BTSGU · BrightSpring Health Services, Inc.
$202.46
+0.88 (+0.44%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$12.10B
Shares
197.86M
Volume · Oct 20
124
Avg daily vol (3M)
19.85K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$201.58
Open$201.58
Day$201.58–201.58
52W close$102.87–240.70
Avg vol 30d9K
Last earningsOct 30, 2026
DataJan 2024–Oct 2026
Filing10-Q · Jul 31
Up next
Next earnings release
Oct 30, 2026
Announced
· in 1 wks
Next earnings call
Oct 30, 2026
Scheduled
· in 1 wks
filed Jul 31, 2026
call held Jul 31, 2026
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Guidance & track record
Latest guidance
· from the 8-K filed Jul 31, 2026
Revenues
· full year 2026
Raised
$15.1B – $15.43B
May 1, 2026
$14.73B – $15.23B
changed to
Jul 31, 2026
$15.1B – $15.43B
prior FY $12.91B
midpoint +18.2% Y/Y
Pharmacy Segment Revenue
· full year 2026
Raised
$13.2B – $13.5B
May 1, 2026
$12.85B – $13.3B
changed to
Jul 31, 2026
$13.2B – $13.5B
Provider Segment Revenue
· full year 2026
Raised
$1.9B – $1.93B
May 1, 2026
$1.88B – $1.93B
changed to
Jul 31, 2026
$1.9B – $1.93B
Total Adjusted EBITDA
· full year 2026
Non-GAAP
Raised
$820M – $845M
May 1, 2026
$795M – $825M
changed to
Jul 31, 2026
$820M – $845M
Prior guidance
period ended
· from the Earnings Call filed Oct 28, 2025
Adjusted EBITDA
· 2025
$605M – $615M
Total revenue
· 2025
$12.5B – $12.8B
Pharmacy Solutions revenue
· 2025
$11.05B – $11.3B
Provider services revenue
· 2025
$1.45B – $1.5B
Total adjusted EBITDA
· full year 2025
$605M – $615M
Operating cash flow
· full year 2025
at least $300M
Guided vs delivered
· last 2 settled
Total revenue
2025
guided $12.5B – $12.8B
$12.91B
Beat +2.1%
Net revenue
full year 2024
guided $10.45B – $10.9B
$10.07B
Miss −5.6%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders illustrative — not investment adviceMarket signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $199 › 200d $173 — 50d above 200d
Institutional flow
Distributing
52 of 443 funds reported for Sep 30 · net -19.5K sh shares · +16 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
No short-interest data
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
443 holders — near 2-yr high, broad support
Price context
position in its 52-week range
Range low $103
Now $202 · 72%
Range high $241
vs 200-day avg +17%
vs 50-day avg +1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | 395M | Six Months Ended June 30, 2026 | — |
| Adjusted EPS non-GAAP | $0.83 | six months ended June 30, 2026 | — |
| Corporate Costs | -49M | Three Months Ended June 30, 2026 | — |
| EBITDA | 171.81M | three months ended June 30, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net income from continuing operations 86.6M
+6.91M Income tax expense
+36.88M Interest expense, net
+41.42M Depreciation and amortization
= EBITDA 171.81M
|
|||
| First Lien Facility paydown | $300M | second quarter of 2026 filing | — |
| Gross Profit per script ($) | $27.5 | Three Months Ended June 30, 2026 | — |
| Home Health Care average daily census | 46,448 | Three Months Ended June 30, 2026 | — |
| Personal Care persons served | 16,357 | Three Months Ended June 30, 2026 | — |
| Pharmacy Solutions segment EBITDA non-GAAP | 180M | Three Months Ended June 30, 2026 | — |
| Prescriptions dispensed | 10,844,038 | Three Months Ended June 30, 2026 | — |
| Provider Services segment EBITDA non-GAAP | 75M | Three Months Ended June 30, 2026 | — |
| Rehab Care persons served | 7,755 | Three Months Ended June 30, 2026 | — |
| Revenue per script ($) | $314.2 | Three Months Ended June 30, 2026 | — |
| Segment EBITDA non-GAAP | $74.86M | the three months ended June 30, 2026 filing | — |
| Total Segment Adjusted EBITDA non-GAAP | 255M | Three Months Ended June 30, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BTSGU
this stock
BrightSpring Health Services, Inc.
|
$12.10B | +59.7% | +28.2% | — | — |
|
VEEV
Veeva Systems Inc
|
$51.57B | +41.9% | +28.1% | 52.1 | 3.0% |
|
PMDIY
Pro Medicus Ltd./ADR
|
$12.77B | -26.4% | — | — | 0.0% |
|
TEM
Tempus AI, Inc.
|
$11.61B | +9.0% | +83.4% | — | 13.9% |
|
HNGE
Hinge Health, Inc.
|
$8.39B | +123.8% | +50.6% | 78.1 | 7.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BTSGU | -2.5% | +1.4% | +33.6% | +7.0% | +59.7% |
| SPY | -1.5% | -0.9% | +7.7% | +0.5% | +12.4% |
| vs SPY | -1.0% | +2.3% | +25.9% | +6.5% | +47.3% |
Capital returns
Latest dividend
$0.844
/ share · ex Oct 15, 2026
Paid (TTM)
$3.376
/ share · 4 payouts
Dividend yield (TTM, derived)
1.67%
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.